Enterprise Financial Services Corp (EFSC)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-101
| Closed | -$20K | – | 1195 |
|
|
2021
Q2 | $20K | Sell |
101
-11
| -10% | -$2.3K | ﹤0.01% | 590 |
|
|
2021
Q1 | $24K | Buy |
112
+21
| +23% | +$4.61K | ﹤0.01% | 555 |
|
|
2020
Q4 | $22K | Sell |
91
-6
| -6% | -$1.38K | ﹤0.01% | 558 |
|
|
2020
Q3 | $26K | Hold |
97
| – | – | 0.01% | 502 |
|
|
2020
Q2 | $28K | Buy |
97
+14
| +17% | +$3.8K | 0.01% | 483 |
|
|
2020
Q1 | $20K | Hold |
83
| – | – | 0.01% | 510 |
|
|
2019
Q4 | $18K | Sell |
83
-5
| -6% | -$1.01K | ﹤0.01% | 604 |
|
|
2019
Q3 | $15K | Buy |
88
+32
| +57% | +$5.66K | ﹤0.01% | 633 |
|
|
2019
Q2 | $10K | Buy |
56
+10
| +22% | +$1.75K | ﹤0.01% | 746 |
|
|
2019
Q1 | $8K | Buy |
46
+7
| +18% | +$1.29K | ﹤0.01% | 804 |
|
|
2018
Q4 | $6K | Sell |
39
-5
| -11% | -$866 | ﹤0.01% | 629 |
|
|
2018
Q3 | $8K | Buy |
44
+5
| +13% | +$890 | ﹤0.01% | 648 |
|
|
2018
Q2 | $7K | Sell |
39
-26
| -40% | -$4.03K | ﹤0.01% | 665 |
|
|
2018
Q1 | $11K | Buy |
65
+26
| +67% | +$4.25K | 0.01% | 581 |
|
|
2017
Q4 | $6K | Sell |
39
-32
| -45% | -$4.74K | ﹤0.01% | 677 |
|
|
2017
Q3 | $11K | Buy |
71
+14
| +25% | +$2.11K | 0.01% | 572 |
|
|
2017
Q2 | $7K | Buy |
57
+18
| +46% | +$2.17K | ﹤0.01% | 650 |
|
|
2017
Q1 | $4K | Sell |
39
-29
| -43% | -$2.55K | ﹤0.01% | 818 |
|
|
2016
Q4 | $5K | Sell |
68
-26
| -28% | -$2.12K | ﹤0.01% | 767 |
|
|
2016
Q3 | $8K | Hold |
94
| – | – | ﹤0.01% | 648 |
|
|
2016
Q2 | $8K | Buy |
94
+55
| +141% | +$4.75K | ﹤0.01% | 611 |
|
|
2016
Q1 | $3K | Sell |
39
-12
| -24% | -$1.08K | ﹤0.01% | 822 |
|
|
2015
Q4 | $6K | Sell |
51
-12
| -19% | -$1.45K | ﹤0.01% | 700 |
|
|
2015
Q3 | $7K | Buy |
63
+12
| +24% | +$1.54K | ﹤0.01% | 644 |
|
|
2015
Q2 | $6K | Sell |
51
-40
| -44% | -$5.04K | ﹤0.01% | 687 |
|
|
2015
Q1 | $11K | Hold |
91
| – | – | 0.01% | 593 |
|
|
2014
Q4 | $11K | Hold |
91
| – | – | 0.01% | 591 |
|
|
2014
Q3 | $10K | Hold |
91
| – | – | 0.01% | 607 |
|
|
2014
Q2 | $9K | Sell |
91
-11
| -11% | -$771 | 0.01% | 662 |
|
|
2014
Q1 | $7K | Buy |
102
+11
| +12% | +$871 | ﹤0.01% | 731 |
|
|
2013
Q4 | $7K | Hold |
91
| – | – | ﹤0.01% | 696 |
|
|
2013
Q3 | $7K | Sell |
91
-10
| -10% | -$796 | ﹤0.01% | 674 |
|
|
2013
Q2 | $8K | Buy |
+101
| New | +$7.44K | 0.01% | 517 |
|
Other funds holding VRTX
Enterprise Financial Services Corp (EFSC)'s VRTX Position: Q3 2021 in Review
Enterprise Financial Services Corp (EFSC) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 101 shares — an estimated $20K sold.
Enterprise Financial Services Corp (EFSC) first reported a position in VRTX in Q2 2013 and held it in 33 quarters. The position peaked at $28K in Q2 2020. 935 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.
- Enterprise Financial Services Corp (EFSC) reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Enterprise Financial Services Corp (EFSC) sold 101 Vertex Pharmaceuticals shares in Q3 2021, an estimated $20K.
- Enterprise Financial Services Corp (EFSC) first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 33 quarters.
- Enterprise Financial Services Corp (EFSC)'s Vertex Pharmaceuticals position peaked at $28K in Q2 2020.
- 935 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.
Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.